Search - tctmd.com

Displaying 101 - 120 of 193

Sort: Relevancy | Date

News Opinion Fellow Talk

Top 10 Tricks for Choosing the Right Stent

Yael L. Maxwell

August 20, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Industry News

iVascular completes recruitment of patients for its ANCHOR clinical trial of the sirolimus eluting stent ANGIOLITE

May 19, 2016

News Daily News

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Michael O'Riordan

March 30, 2016

News Industry News

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

February 01, 2016

News Features

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Michael O'Riordan

January 06, 2016

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

News Daily News

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Todd Neale

November 16, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

News Industry News

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

October 12, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Industry News

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

September 21, 2015

News Daily News

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

Yael L. Maxwell

September 14, 2015

News Conference News ESC 2015

ABSORB Trials Pit BRS Against Second-Generation DES

Caitlin E. Cox

September 02, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Industry News

U.S. to vie with India for top bioabsorbable stent market after FDA approval

June 25, 2015

News Daily News

BRS Strut Width Tied to Increased Periprocedural MI

June 02, 2015

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Daily News

MASTER: Potential Mortality Advantage With Mesh-Covered Stent in STEMI Patients at 1 Year

Yael L. Maxwell

February 19, 2015

Advertisement

Top 10 Tricks for Choosing the Right Stent

The Bioresorbable Stent Story So Far: What Promise? What Price?

iVascular completes recruitment of patients for its ANCHOR clinical trial of the sirolimus eluting stent ANGIOLITE

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

Boston Scientific Announces Scheduled Presentations At TCT 2015

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

ABSORB Trials Pit BRS Against Second-Generation DES

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

U.S. to vie with India for top bioabsorbable stent market after FDA approval

BRS Strut Width Tied to Increased Periprocedural MI

Trials Explore the Potential of Biodegradable-Polymer Stents

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

MASTER: Potential Mortality Advantage With Mesh-Covered Stent in STEMI Patients at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content